Analytical Data
-
Gene name
S100A16
- Application
-
Alternative Names
S100A16；S100F；Protein S100-A16
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96FQ6
-
Expression Region
1-103aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSHMSDCYTELEK AVIVLVENFY KYVSKYSLVK NKISKSSFRE MLQKELNHML SDTGNRKAAD KLIQNLDANH DGRISFDEYW TLIGGITGPI AKLIHEQEQQ SSS
-
Molecular Weight
14 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
S100A16 is a member of the S100 protein family, which consists of small calcium-binding proteins that play crucial roles in various intracellular processes and intercellular signaling. With a molecular weight of approximately 10 kDa, S100A16 is primarily expressed in tissues such as the skin, testis, and kidney. It has been implicated in several physiological and pathological processes, including cell differentiation, apoptosis, and inflammation. Recent studies have highlighted its potential involvement in cancer progression and metastasis, particularly in cancers such as breast and lung cancer. Due to its unique expression patterns and regulatory functions, S100A16 has garnered attention as a potential biomarker and therapeutic target. Research into the recombinant production of S100A16 aims to facilitate the detailed study of its functional properties, structural characteristics, and interactions with other proteins, thereby providing insights into its role in health and disease. Recombinant S100A16 can be used in various applications, including mechanistic studies, drug screening, and the development of diagnostic tools, thereby contributing to the understanding of its biological significance and therapeutic potential.
